148 related articles for article (PubMed ID: 35926797)
1. Synthesis and human monoamine oxidase inhibitory activity of novel C2-, C3- and C4-substituted phthalonitriles.
Elzien Alamin Ali H; Ozalp L; Danış Ö; Odabaş Z
Bioorg Med Chem Lett; 2022 Oct; 74():128917. PubMed ID: 35926797
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
Agrawal N; Mishra P
Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibition by C4-substituted phthalonitriles.
Manley-King CI; Bergh JJ; Petzer JP
Bioorg Chem; 2012 Feb; 40(1):114-124. PubMed ID: 22100142
[TBL] [Abstract][Full Text] [Related]
4. Design of enamides as new selective monoamine oxidase-B inhibitors.
Kavully FS; Oh JM; Dev S; Kaipakasseri S; Palakkathondi A; Vengamthodi A; Abdul Azeez RF; Tondo AR; Nicolotti O; Kim H; Bijo Mathew
J Pharm Pharmacol; 2020 Jul; 72(7):916-926. PubMed ID: 32246471
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
Legoabe LJ; Petzer A; Petzer JP
Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
[TBL] [Abstract][Full Text] [Related]
6. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
7. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
8. Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from
Chaurasiya ND; Zhao J; Pandey P; Doerksen RJ; Muhammad I; Tekwani BL
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813423
[TBL] [Abstract][Full Text] [Related]
9. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
[TBL] [Abstract][Full Text] [Related]
10. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
[TBL] [Abstract][Full Text] [Related]
11. Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease.
Dawbaa S; Evren AE; Sağlik BN; Gundogdu-Karaburun N; Karaburun AC
Future Med Chem; 2022 Nov; 14(22):1663-1679. PubMed ID: 36317547
[No Abstract] [Full Text] [Related]
12. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
[TBL] [Abstract][Full Text] [Related]
15. Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
Park HR; Kim J; Kim T; Jo S; Yeom M; Moon B; Choo IH; Lee J; Lim EJ; Park KD; Min SJ; Nam G; Keum G; Lee CJ; Choo H
Bioorg Med Chem; 2013 Sep; 21(17):5480-7. PubMed ID: 23810676
[TBL] [Abstract][Full Text] [Related]
16. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease.
Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H
J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
Di Pietro O; Alencar N; Esteban G; Viayna E; Szałaj N; Vázquez J; Juárez-Jiménez J; Sola I; Pérez B; Solé M; Unzeta M; Muñoz-Torrero D; Luque FJ
Bioorg Med Chem; 2016 Oct; 24(20):4835-4854. PubMed ID: 27396685
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.
Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Firgang SI; Suponitsky KY
Bioorg Med Chem Lett; 2015 Mar; 25(6):1206-11. PubMed ID: 25701250
[TBL] [Abstract][Full Text] [Related]
20. Selected chromone derivatives as inhibitors of monoamine oxidase.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
